Is Shelter Pharma Ltd (543963) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Shelter Pharma Ltd is a below average quality company .

Is Shelter Pharma Ltd (543963) undervalued or overvalued?

The key valuation ratios of Shelter Pharma Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Shelter Pharma Ltd (543963) share price return in the past 10 years?

Data is not available for this company

Is Shelter Pharma Ltd (543963) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shelter Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Shelter Pharma Ltd (543963)?

Company share prices are keep on changing according to the market conditions. The current trading price of Shelter Pharma Ltd (543963) on 30-Apr-2026 16:59:59 at 16:59 is 30.39.

What is the P/E ratio of Shelter Pharma?

The latest standalone P/E ratio of Shelter Pharma as of 30-Apr-2026 is 7.02.

What is the P/B ratio of Shelter Pharma Ltd (543963)?

The latest standalone P/B ratio of Shelter Pharma Ltd (543963) as of 30-Apr-2026 is 0.85.

What is the 52-week high and low of Shelter Pharma Ltd (543963)?

The 52-week high of Shelter Pharma Ltd (543963) is Rs. 50.00 and the 52-week low is Rs. 26.50.

Shelter Pharma Ltd (543963) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Shelter Pharma Ltd (543963)
Brand: Shelter Pharma

Key Metrics

Market Cap

₹51 Cr.

P/E Ratio

7.02

Price to Book (P/B)

0.85

Price to Sales (P/S)

1.00

EV/EBITDA

4.81

Return on Capital Employed (ROCE)

25.07%

Current Price

₹30.4

Return on Equity (ROE)

18.88%

Return on Assets (ROA)

16.14%

Operating Profit Margin

19.9%

Net Profit Margin

14.29%

Gross Profit Margin

19.6%

Book Value per Share

₹35.8

Sales Growth (YoY)

26.59%

Sales Growth (3 Years)

19%

Operating Profit Growth (1 Year)

14.45%

Operating Profit Growth (3 Years)

54.27%

Net Profit Growth (1 Year)

16.77%

52-Week Low / High

₹27 / 50

Net Profit Growth (3 Years)

57.94%

Dividend Yield

0.97%

Promoter Holding

44.99%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Shelter Pharma Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of -21.06% based on the current price.

Q.1 Revenue growth of Shelter Pharma Ltd?

Shelter Pharma Ltd revenue growth is 26.6% for FY-2025, which is above its 5-year CAGR of 11%, indicating faster growth.

Q.1 Which industry/sub-sector does Shelter Pharma Ltd belong to?

Shelter Pharma Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Promoter shareholding and pledge status of Shelter Pharma Ltd?

Promoters hold 44.99% of the Shelter Pharma Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Shelter Pharma Ltd vs industry peers?

Shelter Pharma Ltd revenue CAGR is 11.00%, compared to the industry median CAGR of 8.30%, indicating faster growth and gaining its market share.

DeciZen - make an informed investing decision on Shelter Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Shelter Pharma stock performance

Key Ratios

Is Shelter Pharma Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0.7%	0.9%	1.2%	1.3%	1.8%	1.3%	36.2%	59.6%	33.6%	25.1%	-
Value Creation Index ⓘ	-1.0	-0.9	-0.9	-0.9	-0.9	-0.9	1.6	3.3	1.4	0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	28.1	30	31.5	27.7	30.1	22.5	30.1	36.2	40	50.7	51
Sales YoY Gr.	-	6.7%	4.8%	-11.9%	8.4%	-25.2%	33.7%	20.3%	10.7%	26.6%	-
Adj EPS ⓘ	0.1	0.1	0.1	0.1	0.1	0.1	2.4	7.5	5.4	6.3	4.3
YoY Gr.	-	16.7%	0%	14.3%	37.5%	-45.5%	3850%	217.7%	-28.8%	16.8%	-
BVPS (₹) ⓘ	8.7	8.8	8.5	8.6	8.2	8	10.3	17.6	30.2	36.1	35.8
Adj Net Profit ⓘ	0.1	0.1	0.1	0.1	0.1	0	1.8	5.8	6.2	7.2	7
Cash Flow from Ops. ⓘ	0	-0.2	0.4	0	-0.3	-0.3	0.5	-1	-2	5.5	-
Debt/CF from Ops. ⓘ	0	-0.5	0.2	0	-0.9	-0	0.3	-1.9	-0.3	0.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	6.8%	11%	19%	26.6%
Adj EPS ⓘ	67.6%	124.4%	38.2%	16.8%
BVPSⓘ	17.1%	34.6%	51.9%	19.8%
Share Price	-	-	-	-21.1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.6	0.6	0.7	0.8	1.1	0.6	22.9	49.7	24.6	18.4	12
Op. Profit Mgn % ⓘ	0.6	-2.3	0.5	0.7	0.8	0.9	9.1	22.3	22	19.9	NAN
Net Profit Mgn % ⓘ	0.2	0.2	0.2	0.2	0.3	0.2	6.1	16.1	15.5	14.3	14.3
Debt to Equity ⓘ	0.3	0	0	0	0	0	0	0.1	0	0	-
Working Cap Days ⓘ	112	106	97	105	97	127	107	144	231	253	0
Cash Conv. Cycle ⓘ	67	62	53	54	52	74	69	113	152	139	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	4.3	-
TTM Sales (₹ Cr.)	50.7	-
BVPS (₹) ⓘ	35.8	-
Reserves (₹ Cr.) ⓘ	43	-
P/BV ⓘ	0.85	-
PE ⓘ	7.02	-

From the Market
52 Week Low / High (₹)	26.50 / 50.00
All Time Low / High (₹)	26.50 / 80.90
Market Cap (₹ Cr.)	50.8
Equity (₹ Cr.)	16.7
Face Value (₹)	10
Industry PE ⓘ	43.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Shelter Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	28.14	30.01	31.46	27.73	30.07	22.48	30.06	36.15	40.02	50.66
Operating Expenses ⓘ +	27.98	30.70	31.30	27.55	29.82	22.29	27.32	28.09	31.24	40.60
Manufacturing Costs	0.21	0.40	0.47	0.42	0.32	0.21	0.21	0.33	0.31	0.31
Material Costs	26.34	28.73	29.22	25.70	28.30	21.14	25.85	26.25	28.92	37.03
Employee Cost	0.43	0.47	0.52	0.39	0.39	0.33	0.35	0.45	0.63	1.22
Other Costs ⓘ	1.02	1.09	1.09	1.04	0.82	0.62	0.91	1.05	1.38	2.04
Operating Profit ⓘ	0.16	-0.69	0.16	0.18	0.24	0.19	2.74	8.07	8.79	10.06
Operating Profit Margin (%)	0.6%	-2.3%	0.5%	0.7%	0.8%	0.8%	9.1%	22.3%	22.0%	19.9%
Other Income ⓘ +	0	0.83	0.01	0.02	0.01	0.01	0.02	0	0.01	0.02
Exceptional Items ⓘ	0	0	0	0	0	0	0	-0.90	0	0
Interest ⓘ	0.01	0.01	0	0	0.01	0.02	0.08	0.03	0.26	0.13
Depreciation ⓘ	0.10	0.07	0.10	0.12	0.13	0.12	0.17	0.16	0.25	0.27
Profit Before Tax ⓘ	0.05	0.06	0.07	0.08	0.11	0.06	2.51	6.98	8.28	9.68
Tax ⓘ	0.01	0.01	0.01	0.02	0.03	0.02	0.67	1.78	2.08	2.44
Profit After Tax	0.05	0.05	0.05	0.06	0.08	0.04	1.84	5.21	6.20	7.24
PAT Margin (%)	0.2%	0.2%	0.2%	0.2%	0.3%	0.2%	6.1%	14.4%	15.5%	14.3%
Adjusted EPS (₹)	0.1	0.1	0.1	0.1	0.1	0.1	2.4	6.7	5.4	6.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	6.20%	5.60%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	7.77	7.78	7.63	7.69	6.98	7.11	8.93	14.55	35.82	42.72
Share Capital ⓘ	0.45	0.45	0.45	0.45	0.45	0.48	0.48	7.74	11.56	11.56
Reserves ⓘ	7.31	7.32	7.17	7.23	6.53	6.63	8.44	6.81	24.26	31.16
Debt +	2.07	0.11	0.07	0.16	0.24	0	0.10	1.78	0.58	1.04
Long Term Debt	0	0	0	0	0	0	0.06	0.48	0.57	0.93
Short Term Debt	2.07	0.11	0.07	0.16	0.24	0	0.04	1.30	0	0.11
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.18	0.17	0.15	0.19	0.26	0.31	0.32	0.47	0.71	1.25
Others Liabilities ⓘ	1.53	3.58	2.96	2.97	3.15	2.77	3.49	4.65	4.28	3.29
Total Liabilities ⓘ	11.56	11.64	10.81	11	10.63	10.20	12.84	21.45	41.38	48.30
Fixed Assets
Net Fixed Assets ⓘ +	2.61	2.71	2.67	2.69	1.77	1.57	1.45	1.85	3.58	5.96
Gross Block	3.28	3.31	3.37	3.51	3.11	3.12	3.17	3.72	5.70	8.36
Accumulated Depreciation	0.67	0.60	0.70	0.82	1.34	1.55	1.72	1.88	2.13	2.39
CWIP ⓘ	0.14	0.11	0.13	0.22	0	0	0.55	0	0	0
Investments ⓘ	0	0	0	0	0.68	0.68	0.68	0.68	0.68	0.68
Inventories	4.43	3.91	3.81	4.12	4.31	4.02	5.67	7.96	9.93	12.90
Trade Receivables	1	1.16	0.59	0.06	0.61	0.76	1.61	8.19	8.85	9.47
Cash Equivalents	0.10	0.08	0.08	0.12	0.14	0.37	0.10	0.43	5.04	3.42
Others Assets ⓘ	3.28	3.67	3.53	3.78	3.13	2.81	2.78	2.34	13.31	15.88
Total Assets ⓘ	11.56	11.64	10.81	11	10.63	10.20	12.84	21.45	41.38	48.30

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0.23	0.37	-0.27	-0.28	0.52	-0.96	-1.96	5.48
PBT ⓘ	0.06	0.07	0.11	0.06	2.51	7.05	8.28	9.68
Adjustment ⓘ	0.07	0.10	-0.18	-0.18	0.05	0.17	0.58	0.26
Changes in Working Capital ⓘ	-0.33	0.37	-0.2	-0.17	-2.04	-8.19	-9.26	-2.02
Tax Paid ⓘ	-0.03	-0.16	0	0	0	0	-1.56	-2.44
Cash Flow From Investing Activity ⓘ +	-0.33	-0.34	0.29	0.03	-0.85	0.11	-4.54	-7.13
Capex	-0.13	-0.28	-0.05	-0.01	-0.60	-0	-0.85	-2.65
Net Investments	-0	0	0	0	-0	0	0	0
Others ⓘ	-0.20	-0.06	0.34	0.04	-0.25	0.12	-3.69	-4.48
Cash Flow From Financing Activity ⓘ +	0.54	-0.04	0	0.48	0.06	1.18	11.12	0.03
Net Proceeds from Shares ⓘ	0	0	0	0.48	0	-0.20	10.91	0
Net Proceeds from Borrowing ⓘ	0.54	-0.04	0	0	0.06	0.48	0.09	0.36
Interest Paid ⓘ	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	-0.38
Others ⓘ	0	0	0	0	0	0.90	0.11	0.05
Net Cash Flow ⓘ	-0.02	-0	0.02	0.23	-0.27	0.33	4.61	-1.62

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.74	0.75	0.87	0.96	1.31	0.68	25.95	48.22	25.58	18.88
ROCE (%)	0.71	0.9	1.16	1.33	1.84	1.29	36.17	59.61	33.62	25.07
Asset Turnover Ratio	2.46	2.59	2.8	2.54	2.78	2.16	2.61	2.11	1.27	1.13
PAT to CFO Conversion(x)	0	-4.6	7.4	0	-3.38	-7	0.28	-0.18	-0.32	0.76
Working Capital Days
Receivable Days	13.90	13.10	10.20	4.30	4.10	11.20	14.40	49.50	77.70	66
Inventory Days	55.30	50.70	44.80	52.20	51.20	67.60	58.80	68.90	81.60	82.20
Payable Days	2.30	2.20	2	2.40	2.90	4.90	4.50	5.50	7.50	9.70

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Shelter Pharma Ltd FAQs

The current trading price of Shelter Pharma on 30-Apr-2026 16:59 is ₹30.39.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 29-Apr-2026 the market cap of Shelter Pharma stood at ₹50.83 Cr

The latest P/E ratio of Shelter Pharma as of 29-Apr-2026 is 7.02.

The latest P/B ratio of Shelter Pharma as of 29-Apr-2026 is 0.85.

The 52-week high of Shelter Pharma is ₹50.00 and the 52-week low is ₹26.50.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shelter Pharma is ₹50.66 ( Cr.) .

About Shelter Pharma Ltd

The company was originally converted from a Partnership Firm 'M/s Shelter Pharma' to a Public Limited Company on October 12, 2007 as 'Shelter Pharma Limited' under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli.

The company primarily focuses in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. Shelter started with a few products about decades back. However, over a period of time, it has added products to its portfolio through its in-house R & D efforts backed by sound knowledge of Ayurveda. Shelter is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. It enjoys a good product acceptance and market share in the state of Gujarat. In the Human pharma segment, Shelter has product portfolio of OTC products as well Ethical pharma products. Similarly, Shelter has OTC and Ethical presence in Veterinary segment. Shelter has a respectable track record of efficacy of its products. All the products are priced very competitively considering Shelter’s target market.

Shelter Pharma originally named as Shelter Pharmacy, it was converted to Shelter Pharma Limited on October 12, 2007 under Part IX of The Companies Act, 1956. The company is being promoted by Mr Mustaqim Nisarahmed Sabugar and Mr Shakil Nisarahmed Sabugar. Promoters have nurtured and strengthened the business over the years. The business was slowly expanded from local presence in Himmatnagar to well spread presence in the state of Gujarat. Shelter remained a family enterprise before incorporation of the Company with a consolidated position in Gujarat. Introduction of new generation of promoters, set up of new companies around 2007 brought new ideas and aspirations to the business. Shelter has embarked on a major restructuring drive in line with redefined goals. The company has reworked its organizational structure, product portfolio, distribution network, pricing, packaging and internal processes. It has also invested substantially in strengthening infrastructure with fresh fund infusion to improve its manufacturing capacity in Himmatnagar. Shelter sources required raw material from nearby villages. Its raw material is sourced directly from farmers. Company has long established relationships with farmers, giving it an assured supply of herbs and plants. Shelter focuses on rural/semi urban market as its clientele to offer high quality price competitive remedies to villages.

Business area of the company

The company is engaged in the business of manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary.

Products of the company

Human healthcare

Lemonade barley water
Sherolax
Baldeepak
Stonyl tablet

Veterinary healthcare

Agrical powder
Lactocal gel
Shelodex ultra ointment

History and milestone

2007: Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of ‘Shelter Pharma Limited’.
2008: Received its license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs.
2010: Registered its operations in Kuwait.
2013: Registered its Product Coughnal Cough Syrup in UAE.
2020: Company got ISO certified under ISO 9001:2015.
2023: Added 182 Products to the Product Portfolio of the Company till 2023.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Shelter Pharma Ltd (543963) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Shelter Pharma Share Price